PRMT5 inhibitors on the (myeloma) road
PRMT5 inhibitors on the (myeloma) road |
https://doi.org/10.18632/oncotarget.26392
Annamaria Gulla,
Teru Hideshima,
and Kenneth C. Anderson
|
36646-36647 |
The dual effect of pharmacological ascorbate on radiation: The best of both worlds
The dual effect of pharmacological ascorbate on radiation: The best of both worlds |
https://doi.org/10.18632/oncotarget.26396
Joseph J. Cullen
|
36648-36649 |
Prostate cancer genomics and racial health disparity
Prostate cancer genomics and racial health disparity |
https://doi.org/10.18632/oncotarget.26399
Vanessa M. Hayes,
Weerachai Jaratlerdsiri,
and M.S. Riana Bornman
|
36650-36651 |
Targeting Her2/neu in uterine serous carcinoma: A paradigm shift in management
Targeting Her2/neu in uterine serous carcinoma: A paradigm shift in management |
https://doi.org/10.18632/oncotarget.26413
Salvatore Lopez,
Burak Zeybek,
and Alessandro D. Santin
|
36652-36653 |
Genomic loss of heterozygosity and survival in the REAL3 trial
Genomic loss of heterozygosity and survival in the REAL3 trial |
https://doi.org/10.18632/oncotarget.26336
Elizabeth C. Smyth,
Catherine Cafferkey,
Andrea Loehr,
Tom Waddell,
Ruwaida Begum,
Clare Peckitt,
Thomas C. Harding,
Minh Nguyen,
Alicia F. Okines,
Mitch Raponi,
Sheela Rao,
David Watkins,
Naureen Starling,
Gary W. Middleton,
Jonathan Wadsley,
Wasat Mansoor,
Tom Crosby,
Andrew Wotherspoon,
Ian Chau,
and David Cunningham
|
36654-36665 |
Modulation of double-stranded RNA pattern recognition receptor signaling in ovarian cancer cells promotes inflammatory queues
Modulation of double-stranded RNA pattern recognition receptor signaling in ovarian cancer cells promotes inflammatory queues |
https://doi.org/10.18632/oncotarget.26378
Maria Muccioli,
Harika Nandigam,
Tiffany Loftus,
Manindra Singh,
Amritha Venkatesh,
Julia Wright,
Michelle Pate,
Kelly McCall,
and Fabian Benencia
|
36666-36683 |
SOX2 haploinsufficiency promotes impaired vision at advanced age
SOX2 haploinsufficiency promotes impaired vision at advanced age |
https://doi.org/10.18632/oncotarget.26393
Leire Moreno-Cugnon,
Ander Anasagasti,
Maitane Ezquerra-Inchausti,
Ander Izeta,
Pedro de la Villa,
Javier Ruiz-Ederra,
and Ander Matheu
|
36684-36692 |
Exploiting the transcriptional specificity of the alpha-methylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer
Exploiting the transcriptional specificity of the alpha-methylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer |
https://doi.org/10.18632/oncotarget.26401
Mariya Shapovalova,
Julia Davydova,
Christine Henzler,
Mark Daniel,
Scott M. Dehm,
Christopher A. Warlick,
and Aaron M. LeBeau
|
36693-36704 |
Protein arginine methyltransferase 5 (PRMT5) dysregulation in cancer
Protein arginine methyltransferase 5 (PRMT5) dysregulation in cancer |
https://doi.org/10.18632/oncotarget.26404
Harshita Shailesh,
Zain Z. Zakaria,
Robert Baiocchi,
and Saïd Sif
|
36705-36718 |
Correction: Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height
Correction: Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height |
https://doi.org/10.18632/oncotarget.26429
Katrina Tatton-Brown,
Sandra Hanks,
Elise Ruark,
Anna Zachariou,
Silvana Del Vecchio Duarte,
Emma Ramsay,
Katie Snape,
Anne Murray,
Elizabeth R. Perdeaux,
Sheila Seal,
Chey Loveday,
Siddharth Banka,
Carol Clericuzio,
Frances Flinter,
Alex Magee,
Vivienne McConnell,
Michael Patton,
Wolfgang Raith,
Julia Rankin,
Miranda Splitt,
Volker Strenger,
Clare Taylor,
Patricia Wheeler,
I. Karen Temple,
Trevor Cole,
Jenny Douglas,
and Nazneen Rahman
|
36719-36719 |
Correction 2: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study
Correction 2: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study |
https://doi.org/10.18632/oncotarget.26431
Marina Cazzaniga,
Claudio Verusio,
Mariangela Ciccarese,
Alberto Fumagalli,
Donata Sartori,
Maria Rosaria Valerio,
Mario Airoldi,
Gabriella Moretti,
Corrado Ficorella,
Valentina Arcangeli,
Lucrezia Diodati,
Alberto Zambelli,
Antonio Febbraro,
Daniele Generali,
Mirco Pistelli,
Ornella Garrone,
Antonino Musolino,
Patrizia Vici,
Michela Maur,
Lucia Mentuccia,
Nicla La Verde,
Giulia Bianchi,
Salvatore Artale,
Livio Blasi,
Michela Piezzo,
Francesco Atzori,
Anna Turletti,
Chiara Benedetto,
Maria Concetta Cursano,
Alessandra Fabi,
Vittorio Gebbia,
Alessio Schirone,
Raffaella Palumbo,
Antonella Ferzi,
Antonio Frassoldati,
Claudio Scavelli,
Luca Clivio,
and Valter Torri on behalf of The EVA Study Group
|
36720-36721 |